Authors:
Walpole, R
Olday, J
Haetzman, M
Drummond, GB
Doyle, E
Citation: R. Walpole et al., A comparison of the respiratory effects of high concentrations of halothane and sevoflurane, PAEDIATR AN, 11(2), 2001, pp. 157-160
Authors:
Kaye, SM
Bell, MG
Bell, RE
Bialek, J
Bigelow, T
Bitter, M
Bonoli, P
Darrow, D
Efthimion, P
Ferron, J
Fredrickson, E
Gates, D
Grisham, L
Hosea, J
Johnson, D
Kaita, R
Kubota, S
Kugel, H
LeBlanc, B
Maingi, R
Manickam, J
Mau, TK
Maqueda, RJ
Mazzucato, E
Menard, J
Mueller, D
Nelson, B
Nishino, N
Ono, M
Paoletti, F
Paul, S
Peng, YKM
Phillips, CK
Raman, R
Ryan, P
Sabbagh, SA
Schaffer, M
Skinner, CH
Stutman, D
Swain, D
Synakowski, E
Takase, Y
Wilgen, J
Wilson, JR
Zhu, W
Zweben, S
Bers, A
Carter, M
Deng, B
Domier, C
Doyle, E
Finkenthal, M
Hill, K
Jarboe, T
Jardin, S
Ji, H
Lao, L
Lee, KC
Luhmann, N
Majeski, R
Medley, S
Park, H
Peebles, T
Pinsker, RI
Porter, G
Ram, A
Rensink, M
Rognlien, T
Stotler, D
Stratton, B
Taylor, G
Wampler, W
Wurden, GA
Xu, XQ
Zeng, L
Citation: Sm. Kaye et al., Initial physics results from the National Spherical Torus Experiment, PHYS PLASMA, 8(5), 2001, pp. 1977-1987
Authors:
Osborne, TH
Leonard, AW
Mahdavi, MA
Chu, M
Fenstermacher, ME
La Haye, R
McKee, G
Petrie, TW
Doyle, E
Staebler, G
Wade, MR
Citation: Th. Osborne et al., Gas puff fueled H-mode discharges with good energy confinement above the Greenwald density limit on DIII-D, PHYS PLASMA, 8(5), 2001, pp. 2017-2022
Citation: K. Button et al., Intelligent transport systems in commercial fleet management: A study of short term economic benefits, TRANSP PL T, 24(2), 2001, pp. 155-170
Authors:
Edelstein, PH
Shinzato, T
Doyle, E
Edelstein, MAC
Citation: Ph. Edelstein et al., In vitro activity of gemifloxacin (SB-265805, LB20304a) against Legionellapneumophila and its pharmacokinetics in guinea pigs with L-pneumophila pneumonia, ANTIM AG CH, 45(8), 2001, pp. 2204-2209
Authors:
Doyle, E
Fowles, SE
McDonnell, DF
McCarthy, R
White, SA
Citation: E. Doyle et al., Rapid determination of gemifloxacin in human plasma by high-performance liquid chromatography-tandem mass spectrometry, J CHROMAT B, 746(2), 2000, pp. 191-198
Authors:
Rosing, H
Man, WY
Doyle, E
Bult, A
Beijnen, JH
Citation: H. Rosing et al., Bioanalytical liquid chromatographic method validation. A review of current practices and procedures, J LIQ CHR R, 23(3), 2000, pp. 329-354
Authors:
de Jonge, MJA
Loos, WJ
Gelderblom, H
Planting, AST
van der Burg, MEL
Sparreboom, A
Brouwer, E
van Beurden, V
Mantel, MA
Doyle, E
Hearn, S
Ross, G
Verweij, J
Citation: Mja. De Jonge et al., Phase I pharmacologic study of oral topotecan and intravenous cisplatin: Sequence-dependent hematologic side effects, J CL ONCOL, 18(10), 2000, pp. 2104-2115
Authors:
Akhtar, S
Beckman, RA
Mould, DR
Doyle, E
Fields, SZ
Wright, J
Citation: S. Akhtar et al., Pretreatment with ranitidine does not reduce the bioavailability of orallyadministered topotecan, CANC CHEMOT, 46(3), 2000, pp. 204-210
Authors:
Rosing, H
van Zomeren, DM
Doyle, E
Huinink, WWT
Schellens, JHM
Bult, A
Beijnen, JH
Citation: H. Rosing et al., Quantification of topotecan and its metabolite N-desmethyltopotecan in human plasma, urine and faeces by high-performance liquid chromatographic methods, J CHROMAT B, 727(1-2), 1999, pp. 191-203
Authors:
Semple, D
Russell, S
Doyle, E
Aldridge, LM
Citation: D. Semple et al., Comparison of morphine sulphate and codeine phosphate in children undergoing adenotonsillectomy, PAEDIATR AN, 9(2), 1999, pp. 135-138
Authors:
Johnston, P
Findlow, D
Aldridge, LM
Doyle, E
Citation: P. Johnston et al., The effect of ketamine on 0.25% and 0.125% bupivacaine for caudal epiduralblockade in children, PAEDIATR AN, 9(1), 1999, pp. 31-34
Authors:
Herben, VMM
Panday, VRN
Richel, DJ
Schellens, JHM
van der Vange, N
Rosing, H
Beusenberg, FD
Hearn, S
Doyle, E
Beijnen, JH
Huinink, WWT
Citation: Vmm. Herben et al., Phase I and pharmacologic study of the combination of paclitaxel, cisplatin, and topotecan administered intravenously every 21 days as first-line therapy in patients with advanced ovarian cancer, J CL ONCOL, 17(3), 1999, pp. 747-755
Citation: E. Doyle et C. Liu, A case of acquired iris depigmentation as a possible complication of levobunolol eye drops, BR J OPHTH, 83(12), 1999, pp. 1405-1406
Authors:
Klein, C
Vieregge, P
Hagenah, J
Sieberer, M
Doyle, E
Jacobs, H
Gasser, T
Breakefield, XO
Risch, NJ
Ozelius, LJ
Citation: C. Klein et al., Search for the PARK3 founder haplotype in a large cohort of patients with Parkinson's disease from Northern Germany, ANN HUM GEN, 63, 1999, pp. 285-291